Chu Yu-Waye bought CTMX
September 26, 2025 · Form 4 insider transaction
Chu Yu-Waye bought 43,750 shares of CytomX Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
43,750
Price
$0.00
Total value
N/A
InsiderChu Yu-Waye
RoleOfficer
SecurityPerformance Stock Units (PSUs)
Transaction codeA: Grant or award
Transaction dateSeptember 26, 2025
Filing dateSeptember 30, 2025
Shares owned after43,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Performance Stock Unit ("PSU") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date.